We specialise in full-service custom research and consultancy for global healthcare. We use the full range of qualitative and quantitative techniques to undertake both ad hoc and tracking studies across a range of therapy areas and territories
Within prescription medicines, we have therapeutic specialists and experience in a broad range of therapy areas from chronic illnesses to rare diseases.
Consumer health and nutritionals
We combine our knowledge of the pharmaceutical sector with our understanding of patients and consumers to deliver integrated insights.
Medical devices and diagnostics
Our experience covers everything from insulin pens to large-scale surgical console systems. We use our knowledge of the unique market dynamics and regulatory nature of this sector to improve client understanding.
- Some example case studiesQualitative segmentation validation study with backroom brainstorm exercises
The challengeOur client had an oncology product in development for the treatment of prostate cancer. The company wanted to conduct research to inform future planning, list development, advisory board creation, and initial communications platforms. In an earlier quantitative wave of research we had identified four segments to define physician treatment and prescription behaviors. Our next challenge was to validate the segmentation. Our client wanted to…read more »Device Attribute Testing
The challengeOur client wanted to determine the optimal new blood glucose monitoring device – one that would best retain their current customers and also attract new ones. They also wanted to be able to rationalise the strengths of their existing portfolio against their competitors. The patient evaluation needed to reflect real life as much as possible, so that it truly reflected patient preference and could…read more »Corporate Equity Survey
The challengeOur client’s senior management wanted to assess its company’s image amongst their key HCP stakeholders. The client wanted to measure familiarity and perceptions of the company versus its competitors, particularly in light of recent corporate announcements. They also wanted to identify opportunities for influencing customer opinion. The solututionIt was critical for the results to be globally robust, so we conducted online interviews with 1,500…read more »
- Our latest white papersPunching above your weight: Combining behavioural and attitudinal data to strengthen segmentations
In this paper we examine the differences between behavioural and attitudinal approaches to segmentation and outline how integration of the two can best be achieved to strengthen segmentation solutionsread more »Will gene therapies finally be commercially viable to pharma?
Our latest Free Thinking white paper explores the science behind the idea of gene therapy and takes a look at some of the core challenges medical researchers have faced when attempting to develop this technology. We review gene therapy’s chequered past, look at recent developments in this field and consider the future for gene therapies on their way to market.read more »